✦ LIBER ✦

601 A First-in-human, Phase 1 Clinical Study of the Safety, Tolerability and Pharmacokinetics (PK) of G-202, a Thapsigargin-based PSMA-activated Prodrug, in Patients with Advanced Solid Tumors

✍ Scribed by Mahalingam, D.; Wilding, G.; Denmeade, S.; Sarantopoulas, J.; Cosgrove, D.; Cetnar, J.; Azad, N.; Bruce, J.; Kurman, M.; Carducci, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

50 A phase I study of the safety, tolera

✍ H. Richly; S.D. Rubin; A. Madi; M. Jeffels; B. Nokay; D. Gibson; S. Weller; M.E. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A Phase I study to assess the safety, to

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

580 First-in-human, Safety, Pharmacokine

✍ Dienstmann, R.; Lassen, U.; Cebon, J.; Desai, J.; Brown, M.P.; Evers, S.; Su, F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

385 A first in human phase 1 study of th

✍ K. Papadopoulos; S. Crippa; A. Hanssen; A. Montagnoli; F. Fiorentini; A.W. Tolch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

87 Inhibition of Autophagy: a Phase 1 Sa

✍ Mahalingam, D.; Mita, M.; Sarantopoulos, J.; Amaravadi, R.; Davis, L.; Mita, A.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A first in human, safety, pharmacokineti

✍ Jonathan W Goldman, Robert N Raju, Gregory A Gordon, Iman El-Hariry… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 404 KB